{"id":"https://openalex.org/W2642015544","doi":"https://doi.org/10.1016/j.tips.2017.05.010","title":"Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs","display_name":"Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs","publication_year":2017,"publication_date":"2017-06-22","ids":{"openalex":"https://openalex.org/W2642015544","doi":"https://doi.org/10.1016/j.tips.2017.05.010","mag":"2642015544","pmid":"https://pubmed.ncbi.nlm.nih.gov/28648526"},"language":"en","primary_location":{"id":"doi:10.1016/j.tips.2017.05.010","doi":"https://doi.org/10.1016/j.tips.2017.05.010","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tips.2017.05.010","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081802485","display_name":"Miles Congreve","orcid":"https://orcid.org/0000-0003-1913-0318","observed_orcids":["https://orcid.org/0000-0003-1913-0318"]},"institutions":[{"id":"https://openalex.org/I4210147697","display_name":"Heptares Therapeutics (United Kingdom)","ror":"https://ror.org/051fk5x88","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147697"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Miles Congreve","raw_affiliation_strings":["Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210147697"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christine Oswald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147697","display_name":"Heptares Therapeutics (United Kingdom)","ror":"https://ror.org/051fk5x88","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147697"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christine Oswald","raw_affiliation_strings":["Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210147697"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016565466","display_name":"Fiona H. Marshall","orcid":"https://orcid.org/0000-0002-8681-005X","observed_orcids":["https://orcid.org/0000-0002-8681-005X"]},"institutions":[{"id":"https://openalex.org/I4210147697","display_name":"Heptares Therapeutics (United Kingdom)","ror":"https://ror.org/051fk5x88","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147697"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Fiona H. Marshall","raw_affiliation_strings":["Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK. Electronic address: fiona.marshall@heptares.com","Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK. Electronic address: fiona.marshall@heptares.com","institution_ids":["https://openalex.org/I4210147697"]},{"raw_affiliation_string":"Heptares Therapeutics Ltd, Biopark, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210147697"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5016565466"],"corresponding_institution_ids":["https://openalex.org/I4210147697"],"apc_list":{"value":7030,"currency":"USD","value_usd":7030},"apc_paid":null,"fwci":1.5119,"has_fulltext":false,"cited_by_count":125,"citation_normalized_percentile":{"value":0.84301733,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"38","issue":"9","first_page":"837","last_page":"847"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.8970000147819519},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/allosteric-modulators","display_name":"allosteric modulators","score":0.9639999866485596},{"id":"https://openalex.org/keywords/allosteric-pocket","display_name":"allosteric pocket","score":0.890999972820282},{"id":"https://openalex.org/keywords/orthosteric-site","display_name":"orthosteric binding site","score":0.7519999742507935},{"id":"https://openalex.org/keywords/allosteric-modulation","display_name":"allosteric modulation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/small-molecule-ligands","display_name":"small-molecule ligands","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.958646833896637},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.7754839658737183},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6970096230506897},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5601626634597778},{"id":"https://openalex.org/C2776038425","wikidata":"https://www.wikidata.org/wiki/Q2649417","display_name":"Allosteric modulator","level":4,"score":0.5498740673065186},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5344388484954834},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.4719209671020508},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4275192618370056},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3763645589351654},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3687681555747986},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3348731994628906},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3195432424545288},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2679256200790405},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.23568806052207947},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17760378122329712},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.08113962411880493},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.tips.2017.05.010","doi":"https://doi.org/10.1016/j.tips.2017.05.010","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tips.2017.05.010","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:28648526","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28648526","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in pharmacological sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.46810001134872437}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W50373758","https://openalex.org/W1230652463","https://openalex.org/W1550129999","https://openalex.org/W1904592173","https://openalex.org/W1968854375","https://openalex.org/W1969027187","https://openalex.org/W1970613671","https://openalex.org/W1973333445","https://openalex.org/W1974405795","https://openalex.org/W1979337045","https://openalex.org/W1997784197","https://openalex.org/W2008728387","https://openalex.org/W2009664257","https://openalex.org/W2019933465","https://openalex.org/W2020548323","https://openalex.org/W2039399096","https://openalex.org/W2047144511","https://openalex.org/W2051994079","https://openalex.org/W2052127045","https://openalex.org/W2052328463","https://openalex.org/W2066514887","https://openalex.org/W2068632511","https://openalex.org/W2073785051","https://openalex.org/W2104963067","https://openalex.org/W2110319068","https://openalex.org/W2113544683","https://openalex.org/W2118770079","https://openalex.org/W2123563726","https://openalex.org/W2145991947","https://openalex.org/W2146933058","https://openalex.org/W2152853006","https://openalex.org/W2155546261","https://openalex.org/W2158038801","https://openalex.org/W2159718916","https://openalex.org/W2161809826","https://openalex.org/W2165775221","https://openalex.org/W2167857702","https://openalex.org/W2248951706","https://openalex.org/W2281046076","https://openalex.org/W2283677448","https://openalex.org/W2295245722","https://openalex.org/W2336133465","https://openalex.org/W2342485871","https://openalex.org/W2414667422","https://openalex.org/W2499343687","https://openalex.org/W2504220478","https://openalex.org/W2516773138","https://openalex.org/W2520646257","https://openalex.org/W2548166139","https://openalex.org/W2560644533","https://openalex.org/W2560722699","https://openalex.org/W2581696375"],"related_works":["https://openalex.org/W4285736861","https://openalex.org/W2788707514","https://openalex.org/W4391037722","https://openalex.org/W4319916464","https://openalex.org/W2973188233","https://openalex.org/W4211028751","https://openalex.org/W2726859623","https://openalex.org/W4400661174","https://openalex.org/W2187134967","https://openalex.org/W7128113776"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":23},{"year":2018,"cited_by_count":19},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-06-30T00:00:00"}